Volume 145, Issue 3, Pages e1 (September 2013)

Slides:

Advertisements

Similar presentations

Risk of recurrence of Barrett’s esophagus after successful endoscopic therapy Rajesh Krishnamoorthi, MD, Siddharth Singh, MD, Karthik Ragunathan, MD,

Advertisements

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis Marjolein Sikkema, Pieter.

Sachin Wani, Dayna Early, Steve Edmundowicz, Prateek Sharma

Volume 153, Issue 3, Pages e2 (September 2017)

The Seattle Protocol Does Not More Reliably Predict the Detection of Cancer at the Time of Esophagectomy Than a Less Intensive Surveillance Protocol

Covering the Cover Gastroenterology

How to Manage a Barrett's Esophagus Patient With Low-Grade Dysplasia

An Unusual Cause of Lower Gastrointestinal Bleeding

Covering the Cover Gastroenterology

Volume 153, Issue 3, Pages e2 (September 2017)

Volume 137, Issue 3, Pages (September 2009)

Volume 146, Issue 5, Pages e1 (May 2014)

Masoud Solaymani–Dodaran, Tim R. Card, Guruprasad P. Aithal, Joe West

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Volume 152, Issue 5, Pages (April 2017)

Volume 149, Issue 3, Pages e3 (September 2015)

Cause-Specific Mortality of People With Barrett's Esophagus Compared With the General Population: A Population-Based Cohort Study Masoud Solaymani–Dodaran,

Volume 154, Issue 8, Pages e5 (June 2018)

Amnon Sonnenberg, Richard H. Lash, Robert M. Genta Gastroenterology

A Model to Determine Absolute Risk for Esophageal Adenocarcinoma

Volume 142, Issue 2, Pages (February 2012)

Volume 146, Issue 4, Pages e1 (April 2014)

Volume 154, Issue 4, Pages e1 (March 2018)

Unusual Case of an Upset Stomach

Patients With Barrett’s Esophagus and Persistent Low-grade Dysplasia Have an Increased Risk for High-grade Dysplasia and Cancer Christine Kestens, G.

Volume 153, Issue 3, Pages e16-e17 (September 2017)

Volume 150, Issue 4, Pages (April 2016)

Volume 154, Issue 4, Pages e7 (March 2018)

Association Between Length of Barrett's Esophagus and Risk of High-grade Dysplasia or Adenocarcinoma in Patients Without Dysplasia Rajeswari Anaparthy,

Sibu Varghese, Pierre Lao–Sirieix, Rebecca C. Fitzgerald

Prateek Sharma, MD, Sachin Wani, MD, Amit Rastogi, MD

Volume 141, Issue 4, Pages e1 (October 2011)

Volume 143, Issue 3, Pages e1 (September 2012)

Esophageal Adenocarcinoma 10 Years After Surgical Resection of Barrett’s Esophagus: Unusual Presentation as Subepithelial Tumor Andreas Probst, Tina.

Risk of Esophageal Adenocarcinoma and Mortality in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis Marjolein Sikkema, Pieter.

Endoscopic Therapy for Barrett's Esophagus

Patrick Hoversten, Fouad Otaki, David A. Katzka

Volume 141, Issue 2, Pages (August 2011)

Volume 143, Issue 4, Pages e1 (October 2012)

Laura Rotundo, Sushil Ahlawat Gastroenterology

The 75th Diamond Anniversary of Gastroenterology: 1943–2018

Patients With Nondysplastic Barrett's Esophagus Have Low Risks for Developing Dysplasia or Esophageal Adenocarcinoma Sachin Wani, Gary Falk, Matthew.

An Unlikely Lesion to Be Identified in the Cervical Esophagus

Volume 133, Issue 2, Pages (August 2007)

Factors Associated With Progression of Barrett’s Esophagus: A Systematic Review and Meta-analysis Rajesh Krishnamoorthi, Siddharth Singh, Karthik Ragunathan,

Incidence of Progression of Persistent Nondysplastic Barrett’s Esophagus to Malignancy Yonne Peters, Judith Honing, Wietske Kievit, Christine Kestens,

Ashwin N. Ananthakrishnan, David Lieberman Gastroenterology

Jeremy P. Dwyer, Patrick Hosking, John Lubel Gastroenterology

Gastric Rupture Gastroenterology

Volume 149, Issue 3, Pages e4 (September 2015)

Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C Gowtham A. Rao, Prashant K. Pandya Gastroenterology

Volume 143, Issue 3, Pages (September 2012)

The Dawning of a New Editorial Board for Gastroenterology

Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo Barjesh Chander Sharma, Praveen.

Volume 156, Issue 5, Pages (April 2019)

Risks Associated With Anesthesia Services During Colonoscopy

Electronic Clinical Challenges and Images in GI

Volume 139, Issue 6, Pages e1 (December 2010)

Esophageal Tumor After Radical Surgery for Gastric Cancer

Volume 138, Issue 6, Pages (May 2010)

Volume 152, Issue 3, Pages e4 (February 2017)

Electronic Clinical Challenges and Images in GI

Prateek Sharma, Gary W. Falk, Allan P

Barrett’s Esophagus in Women: Demographic Features and Progression to High-Grade Dysplasia and Cancer Gary W. Falk, Prashanthi N. Thota, Joel E. Richter,

The Future of Endoscopic Retrograde Cholangiopancreatography

Statin Use Is Associated With a Decreased Risk of Barrett’s Esophagus

A Female Patient With Persistent Epigastric Pain for 1 Week

Jordan E. Axelrad, Sharyle A. Fowler, Sonia Friedman, Ashwin N

Persistence of Nondysplastic Barrett’s Esophagus Is Not Protective Against Progression to Adenocarcinoma Rajesh Krishnamoorthi, Guilherme Piovezani Ramos,

A Rare Tumor of the Liver With a Sudden Presentation

Presentation transcript:

Volume 145, Issue 3, Pages 548-553.e1 (September 2013) Persistence of Nondysplastic Barrett's Esophagus Identifies Patients at Lower Risk for Esophageal Adenocarcinoma: Results From a Large Multicenter Cohort Srinivas Gaddam, Mandeep Singh, Gokulakrishnan Balasubramanian, Prashanthi Thota, Neil Gupta, Sachin Wani, April D. Higbee, Sharad C. Mathur, John D. Horwhat, Amit Rastogi, Patrick E. Young, Brooks D. Cash, Ajay Bansal, John J. Vargo, Gary W. Falk, David A. Lieberman, Richard E. Sampliner, Prateek Sharma Gastroenterology Volume 145, Issue 3, Pages 548-553.e1 (September 2013) DOI: 10.1053/j.gastro.2013.05.040 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Patient flow chart. IM, intestinal metaplasia. Gastroenterology 2013 145, 548-553.e1DOI: (10.1053/j.gastro.2013.05.040) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Decreasing annual risk of EAC and a combined end point of HGD/EAC with persistent NDBE. *P for trend for risk of EAC = .03; **P for trend for risk of HGD and/or EAC = .04. Gastroenterology 2013 145, 548-553.e1DOI: (10.1053/j.gastro.2013.05.040) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 Length of BE, use of PPIs, use of aspirin, and use of statins are compared between the cohorts (P = NS). Gastroenterology 2013 145, 548-553.e1DOI: (10.1053/j.gastro.2013.05.040) Copyright © 2013 AGA Institute Terms and Conditions

Supplemental Figure 1 Survival analysis curves for the 5 groups using Kaplan–Meier analysis. Gastroenterology 2013 145, 548-553.e1DOI: (10.1053/j.gastro.2013.05.040) Copyright © 2013 AGA Institute Terms and Conditions